0 0.0 0.0 00-Week Non-Controlled Double-Blind Trial Adverse Events Reported in > 0% of Patients and More Commonly in Patients Treated with Pioglitazone Hydrochloride 00 mg + Sulfonylurea than in Patients Treated with Pioglitazone Hydrochloride 00 mg + Sulfonylurea 